Robert Dullea

1.3k total citations
14 papers, 479 citations indexed

About

Robert Dullea is a scholar working on Molecular Biology, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert Dullea has authored 14 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Surgery and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert Dullea's work include RNA and protein synthesis mechanisms (3 papers), Pancreatic function and diabetes (3 papers) and RNA Research and Splicing (3 papers). Robert Dullea is often cited by papers focused on RNA and protein synthesis mechanisms (3 papers), Pancreatic function and diabetes (3 papers) and RNA Research and Splicing (3 papers). Robert Dullea collaborates with scholars based in United States and Australia. Robert Dullea's co-authors include Jishu Shi, Kim F. McClure, Spiros Liras, J.H.D. Cate, Santos Carvajal‐Gonzalez, Frank M. Sacks, Fred R. Ward, Elizabeth Montabana, Giacomo Ruotolo and Jeremy D. Furtado and has published in prestigious journals such as PLoS Biology, Arteriosclerosis Thrombosis and Vascular Biology and Nature Structural & Molecular Biology.

In The Last Decade

Robert Dullea

14 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Dullea United States	10	281	95	86	54	42	14	479
Chen‐Sung Lin Taiwan	12	246 0.9×	77 0.8×	105 1.2×	64 1.2×	15 0.4×	23	466
Chang-Han Chen Taiwan	15	285 1.0×	36 0.4×	64 0.7×	101 1.9×	33 0.8×	20	440
Daniel Margerie Germany	10	241 0.9×	46 0.5×	95 1.1×	70 1.3×	26 0.6×	14	453
Joseph Chiesa United Kingdom	7	390 1.4×	263 2.8×	139 1.6×	52 1.0×	58 1.4×	9	748
Sai Mukund Ramakrishnan United States	11	367 1.3×	43 0.5×	62 0.7×	46 0.9×	13 0.3×	27	584
Francine Sirois Canada	14	266 0.9×	345 3.6×	102 1.2×	56 1.0×	107 2.5×	22	694
Agata Maciejak Poland	11	263 0.9×	45 0.5×	138 1.6×	37 0.7×	17 0.4×	18	478
Noah Post United States	10	440 1.6×	43 0.5×	61 0.7×	24 0.4×	41 1.0×	11	547
Gipsy Majumdar United States	13	373 1.3×	70 0.7×	73 0.8×	41 0.8×	34 0.8×	16	511
Nivedita Tiwari United States	13	253 0.9×	49 0.5×	106 1.2×	82 1.5×	39 0.9×	27	567

Countries citing papers authored by Robert Dullea

Since Specialization

Citations

This map shows the geographic impact of Robert Dullea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Dullea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Dullea more than expected).

Fields of papers citing papers by Robert Dullea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Dullea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Dullea. The network helps show where Robert Dullea may publish in the future.

Co-authorship network of co-authors of Robert Dullea

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Dullea. A scholar is included among the top collaborators of Robert Dullea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Dullea. Robert Dullea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Amin, Neeta B., Aditi R. Saxena, Veena Somayaji, & Robert Dullea. (2023). Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of Pharmacology. Clinical Therapeutics. 45(1). 55–70. 25 indexed citations

Aspnes, Gary E., Steven B. Coffey, Anne‐Marie Dechert‐Schmitt, et al.. (2023). Small molecule inhibitors of PCSK9. SAR investigations of head and amine groups. Bioorganic & Medicinal Chemistry Letters. 92. 129394–129394. 1 indexed citations

Filipski, Kevin J., David J. Edmonds, Michelle R. Garnsey, et al.. (2023). Design of Next-Generation DGAT2 Inhibitor PF-07202954 with Longer Predicted Half-Life. ACS Medicinal Chemistry Letters. 14(10). 1427–1433. 1 indexed citations

Furtado, Jeremy D., Giacomo Ruotolo, Stephen J. Nicholls, et al.. (2021). Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease. Arteriosclerosis Thrombosis and Vascular Biology. 42(2). 227–237. 40 indexed citations

Li, Wenfei, Fred R. Ward, Kim F. McClure, et al.. (2019). Structural basis for selective stalling of human ribosome nascent chain complexes by a drug-like molecule. Nature Structural & Molecular Biology. 26(6). 501–509. 54 indexed citations

Lintner, Nathanael G., Kim F. McClure, Donna N. Petersen, et al.. (2017). Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain. PLoS Biology. 15(3). e2001882–e2001882. 94 indexed citations

Dullea, Robert, Christopher T. Salatto, Simone Sciabola, et al.. (2013). Study of CRTC2 Pharmacology Using Antisense Oligonuceotides. Nucleic Acid Therapeutics. 24(2). 127–138. 7 indexed citations

Stanton, Robert V., Simone Sciabola, Christopher T. Salatto, et al.. (2012). Chemical Modification Study of Antisense Gapmers. Nucleic Acid Therapeutics. 22(5). 344–359. 87 indexed citations

Ghosh, Preetam, Robert Dullea, Ronald W. Sarver, et al.. (2009). Comparing 2-nt 3' overhangs against blunt-ended siRNAs: a systems biology based study. BMC Genomics. 10(Suppl 1). S17–S17. 30 indexed citations

10.

Kane, Christopher D., Kimberly A. Stevens, Mehrdad Haghpassand, et al.. (2008). Molecular Characterization of Novel and Selective Peroxisome Proliferator-Activated Receptor α Agonists with Robust Hypolipidemic Activity in Vivo. Molecular Pharmacology. 75(2). 296–306. 18 indexed citations

11.

Chen, Cuiping, et al.. (2008). Utility of a Novel Oatp1b2 Knockout Mouse Model for Evaluating the Role of Oatp1b2 in the Hepatic Uptake of Model Compounds. Drug Metabolism and Disposition. 36(9). 1840–1845. 35 indexed citations

12.

Shi, Jishu, et al.. (2004). The differential effects of IL-1 and TNF-? on proinflammatory cytokine and matrix metalloproteinase expression in human chondrosarcoma cells. Inflammation Research. 53(8). 377–89. 67 indexed citations

13.

Dullea, Robert, John F. Robinson, & Joel S. Bedford. (1999). Nonrandom degradation of DNA in human leukemic cells during radiation-induced apoptosis.. PubMed. 59(15). 3712–8. 8 indexed citations

14.

Gerweck, L.E., et al.. (1994). Influence of Experimental Factors on Intrinsic Radiosensitivity Assays at Low Doses of Radiation: Cell Multiplicity. Radiation Research. 138(3). 361–361. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact